{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:14:45Z","timestamp":1784945685832,"version":"3.55.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ekir.2025.04.038","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T10:27:15Z","timestamp":1745749635000},"page":"2189-2201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Safety of Drugs in Breastfeeding Women With CKD"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4248-6252","authenticated-orcid":false,"given":"Paula","family":"Parnizari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Hladunewich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Zipursky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2025.04.038_bib1","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1542\/peds.2011-3552","article-title":"Breastfeeding and the use of human milk","volume":"129","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.ekir.2025.04.038_bib2","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1542\/peds.2008-3256","article-title":"Prolonged and exclusive breastfeeding reduces the risk of infectious diseases in infancy","volume":"126","author":"Duijts","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.ekir.2025.04.038_bib3","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jpeds.2009.10.040","article-title":"An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products","volume":"156","author":"Sullivan","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.ekir.2025.04.038_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/ajcn\/70.4.525","article-title":"Breast-feeding and cognitive development: a meta-analysis","volume":"70","author":"Anderson","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ekir.2025.04.038_bib6","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1542\/peds.2004-1176","article-title":"Effect of infant feeding on the risk of obesity across the life course: A quantitative review of published evidence","volume":"115","author":"Owen","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ekir.2025.04.038_bib7","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/archinternmed.2009.231","article-title":"Lactation and incidence of premenopausal breast cancer: a longitudinal study","volume":"169","author":"Stuebe","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ekir.2025.04.038_bib8","first-page":"517","article-title":"Breastfeeding and risk of ovarian cancer in two prospective cohorts","volume":"18","author":"Danforth","year":"2007","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ekir.2025.04.038_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/apa.13102","article-title":"Breastfeeding and maternal health outcomes: a systematic review and meta-analysis","volume":"104","author":"Chowdhury","year":"2015","journal-title":"Acta Paediatr Int J Paediatr"},{"key":"10.1016\/j.ekir.2025.04.038_bib9","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/M20-3106","article-title":"The moral imperative to include pregnant women in clinical trials of interventions for COVID-19","volume":"173","author":"Malhame","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2025.04.038_bib10","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1111\/bcp.14538","article-title":"Infant drug exposure via breast milk","volume":"88","author":"Verstegen","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ekir.2025.04.038_bib11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/089033402237904","article-title":"Studying drugs in human milk: time to unify the approach","volume":"18","author":"Begg","year":"2002","journal-title":"J Hum Lact"},{"key":"10.1016\/j.ekir.2025.04.038_bib12","series-title":"Clinical pharmacology Essentials: The Principles Behind the Prescribing Process","author":"Begg","year":"2003"},{"key":"10.1016\/j.ekir.2025.04.038_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/j.1552-4604.1981.tb01759.x","article-title":"Captopril in human blood and breast milk","volume":"21","author":"Devlin","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ekir.2025.04.038_bib14","first-page":"973","article-title":"Maternal Metyrapone use during breastfeeding: safe for the breastfed infant","volume":"3","author":"Duke","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.ekir.2025.04.038_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00314815","article-title":"The excretion of enalapril and enalaprilat in human breast milk","volume":"38","author":"Redman","year":"1990","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ekir.2025.04.038_bib16","first-page":"278","article-title":"Enalapril treatment of a nursing with slightly impaired renal function","volume":"31","author":"Huttunen","year":"1989","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ekir.2025.04.038_bib17","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1046\/j.1365-2125.2001.01327.x","article-title":"Quinapril and its metabolite quinaprilat in human milk","volume":"51","author":"Begg","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ekir.2025.04.038_bib18","first-page":"A303","article-title":"Benazepril and benazeprilat in human plasma and breast milk. Abstracts of the IV World Conference on Clinical Pharmacology & Therapeutics","volume":"36","author":"Kaiser","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ekir.2025.04.038_bib19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2147\/DDDT.S239704","article-title":"Perindopril in breast milk and determination of breastfed infant exposure: a prospective observational study","volume":"14","author":"Leggett","year":"2020","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.ekir.2025.04.038_bib20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/AOG.0000000000003446","article-title":"Transfer of candesartan into human breast milk","volume":"134","author":"Coberger","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ekir.2025.04.038_bib21","article-title":"The concentration of maternal sacubitril\/valsartan transferred into human milk is negligible","volume":"12","author":"Falconi","year":"2024","journal-title":"Front Public Health"},{"key":"10.1016\/j.ekir.2025.04.038_bib22","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/jps.2600660841","article-title":"Spironolactone: relationship between concentrations of dethioacetylated metabolite in human serum and milk","volume":"66","author":"Phelps","year":"1977","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ekir.2025.04.038_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/trgh.2017.0044","article-title":"Case report: induced lactation in a transgender woman","volume":"3","author":"Reisman","year":"2018","journal-title":"Transgend Health"},{"key":"10.1016\/j.ekir.2025.04.038_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1055\/s-2007-999467","article-title":"Oral bretylium tosylate use during pregnancy and subsequent breastfeeding: a case report","volume":"7","author":"Gutgesell","year":"1990","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ekir.2025.04.038_bib25","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.ekir.2022.05.006","article-title":"Potassium and magnesium in breast milk of a woman with Gitelman syndrome","volume":"7","author":"de Jong","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2025.04.038_bib26","first-page":"303","article-title":"Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib","volume":"63","author":"Gr\u00fcnert","year":"2022","journal-title":"JIMD Rep"},{"key":"10.1016\/j.ekir.2025.04.038_bib27","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1471-0528.2006.01232.x","article-title":"Azathioprine and breastfeeding: is it safe?","volume":"114","author":"Sau","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.ekir.2025.04.038_bib28","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1345\/aph.1H152","article-title":"Breast-feeding during maternal use of azathioprine","volume":"40","author":"Moretti","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ekir.2025.04.038_bib29","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1365-2036.2008.03843.x","article-title":"Azathioprine treatment during lactation","volume":"28","author":"Christensen","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ekir.2025.04.038_bib30","first-page":"605","article-title":"Breast-feeding after renal transplantation","volume":"14","author":"Coulam","year":"1982","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ekir.2025.04.038_bib31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2036.2009.03996.x","article-title":"Azathioprine treatment during lactation","volume":"30","author":"Zelinkova","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ekir.2025.04.038_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2125.2006.02639.x","article-title":"Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs","volume":"62","author":"Gardiner","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ekir.2025.04.038_bib33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1258\/om.2011.110013","article-title":"Is breastfeeding safe with azathioprine?","volume":"4","author":"Singh","year":"2011","journal-title":"Obstet Med"},{"key":"10.1016\/j.ekir.2025.04.038_bib34","first-page":"816","article-title":"Breast-feeding by a cyclosporine-treated mother","volume":"97","author":"Munoz-Flores-Thiagarajan","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ekir.2025.04.038_bib35","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/00365520601155266","article-title":"Autoimmune hepatitis among fertile women: strategies during pregnancy and breastfeeding?","volume":"42","author":"Werner","year":"2007","journal-title":"Scand J Gastroenterol"},{"issue":"sup1","key":"10.1016\/j.ekir.2025.04.038_bib36","first-page":"S48","article-title":"Is it safe to continue azathioprine in breast feeding mothers?","volume":"23","author":"Khare","year":"2003","journal-title":"J Obstet Gynaecol (Lahore)"},{"key":"10.1016\/j.ekir.2025.04.038_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/apt.12334","article-title":"Dutch Initiative on Crohn and Colitis. Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease","volume":"38","author":"de Meij","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ekir.2025.04.038_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000491","article-title":"Breastfeeding in women with rheumatic diseases","volume":"8","author":"Ikram","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.ekir.2025.04.038_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000183213","article-title":"Immunosuppressive therapy and breast-feeding after renal transplantation","volume":"37","author":"Grekas","year":"1984","journal-title":"Nephron"},{"key":"10.1016\/j.ekir.2025.04.038_bib40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.hlc.2020.10.007","article-title":"Pregnancy following heart transplantation: A single centre case series and review of the literature","volume":"30","author":"Boyle","year":"2021","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.ekir.2025.04.038_bib41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199801270-00019","article-title":"Breast-feeding during treatment with cyclosporine","volume":"65","author":"Nyberg","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2025.04.038_bib42","first-page":"12","article-title":"Oral Abstracts. 17th Annual Meeting of French Society of Pharmacology and Therapeutics, the 80th Annual Meeting of Society of Physiology, the 34th Pharmacovigilance Meeting","volume":"27","author":"Bernard","year":"2013","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.ekir.2025.04.038_bib43","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.gastro.2018.05.040","article-title":"Exposure concentrations of infants breastfed by women receiving biologic therapies for inflammatory bowel diseases and effects of breastfeeding on infections and development","volume":"155","author":"Matro","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ekir.2025.04.038_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.crohns.2010.10.005","article-title":"Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding","volume":"5","author":"Angelberger","year":"2011","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ekir.2025.04.038_bib45","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.kint.2021.05.010","article-title":"Measurement of the passage of mycophenolic acid into breast milk in a patient with lupus nephritis","volume":"100","author":"Huerta","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2025.04.038_bib46","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s40620-023-01672-2","article-title":"Transfer of mycophenolic acid into human milk","volume":"36","author":"Krutsch","year":"2023","journal-title":"J Nephrol"},{"key":"10.1016\/j.ekir.2025.04.038_bib47","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bpobgyn.2014.09.001","article-title":"Breast-feeding after transplantation","volume":"28","author":"Constantinescu","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ekir.2025.04.038_bib48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7182\/pit2013803","article-title":"Safety considerations: breastfeeding after transplant","volume":"23","author":"Thiagarajan","year":"2013","journal-title":"Prog Transplant"},{"key":"10.1016\/j.ekir.2025.04.038_bib49","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/nu10030267","article-title":"Low transfer of tacrolimus and its metabolites into colostrum of graft recipient mothers","volume":"10","author":"Kociszewska-Najman","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.ekir.2025.04.038_bib50","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1177\/0961203318809178","article-title":"Changes in the blood level, efficacy, and safety of tacrolimus in pregnancy and the lactation period in patients with systemic lupus erythematosus","volume":"27","author":"Hiramatsu","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.ekir.2025.04.038_bib51","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/jcpt.13451","article-title":"Tacrolimus concentrations after renal transplantation in a mother-neonate dyad: maternal, neonatal and breast milk measurements","volume":"46","author":"Akamine","year":"2021","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.ekir.2025.04.038_bib52","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/01.AOG.0000164052.66219.c7","article-title":"Breastfeeding during tacrolimus therapy","volume":"107","author":"Gardiner","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ekir.2025.04.038_bib53","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2215\/CJN.06400612","article-title":"Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants","volume":"8","author":"Bramham","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2025.04.038_bib54","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/bcp.12122","article-title":"Tacrolimus placental transfer at delivery and neonatal exposure through breast milk","volume":"76","author":"Zheng","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ekir.2025.04.038_bib55","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1345\/aph.1C312","article-title":"Milk transfer and neonatal safety of tacrolimus","volume":"37","author":"French","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ekir.2025.04.038_bib56","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00007890-199708270-00002","article-title":"Pregnancy after liver transplantation under tacrolimus","volume":"64","author":"Jain","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2025.04.038_bib57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1620\/tjem.234.51","article-title":"Safety of tacrolimus treatment during pregnancy and lactation in systemic lupus erythematosus: a report of two patients","volume":"234","author":"Izumi","year":"2014","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.ekir.2025.04.038_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2024.02.989","article-title":"Toxic milk- should we still be afraid of breastfeeding while on tacrolimus therapy: A case study","volume":"43","author":"Kuczaj","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ekir.2025.04.038_bib59","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/AOG.0b013e31825f01f8","article-title":"Pregnancy in an intestinal transplant recipient","volume":"120","author":"Gomez-Lobo","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ekir.2025.04.038_bib60","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1097\/TP.0b013e3182654d36","article-title":"Follow-up of tacrolimus breastfed babies","volume":"94","author":"Gouraud","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2025.04.038_bib61","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.transproceed.2019.02.071","article-title":"Pregnancy after liver transplant: neonatal outcomes and long-term maternal follow-up","volume":"51","author":"Nure","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ekir.2025.04.038_bib62","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/lt.25785","article-title":"Successful pregnancy in a liver transplant recipient on Belatacept","volume":"26","author":"Klintmalm","year":"2020","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ekir.2025.04.038_bib63","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/bmj.286.6365.603","article-title":"Successful pregnancy in a renal transplant recipient taking cyclosporin A","volume":"286","author":"Lewis","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.ekir.2025.04.038_bib64","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.1002\/ibd.21765","article-title":"Cyclosporine in the management of severe ulcerative colitis while breast-feeding","volume":"17","author":"Lahiff","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ekir.2025.04.038_bib65","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1797.2010.01395.x","article-title":"Cyclosporine and lactation","volume":"16","author":"Morton","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ekir.2025.04.038_bib66","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.3390\/nu12092713","article-title":"Low content of cyclosporine A and its metabolites in the colostrum of post-transplant mothers","volume":"12","author":"Kociszewska-Najman","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.ekir.2025.04.038_bib67","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-4632.2012.05534.x","article-title":"Levels of cyclosporine in breast milk and passage into the circulation of the infant of a mother with psoriasis","volume":"53","author":"Mazzuoccolo","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ekir.2025.04.038_bib68","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/FTD.0b013e318208e3a4","article-title":"Cyclosporine and lactation: when the mother is willing to breastfeed","volume":"33","author":"Osadchy","year":"2011","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ekir.2025.04.038_bib69","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1097\/01.TP.0000066352.86763.D0","article-title":"Cyclosporine excretion into breast milk","volume":"75","author":"Moretti","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2025.04.038_bib70","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/bmj.315.7106.463","article-title":"Successful breast feeding while mother was taking cyclosporin","volume":"315","author":"Thiru","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ekir.2025.04.038_bib71","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-2008-1026581","article-title":"[Detection of cyclosporin A in breast milk--is breast feeding contraindicated?]","volume":"49","author":"Behrens","year":"1989","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.ekir.2025.04.038_bib72","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-2008-1067628","article-title":"[Pregnancy during cyclosporin medication following a kidney transplant]","volume":"113","author":"Ziegenhagen","year":"1988","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.ekir.2025.04.038_bib73","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0272-6386(85)80138-4","article-title":"The presence of cyclosporine in body tissues and fluids during pregnancy","volume":"5","author":"Flechner","year":"1985","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2025.04.038_bib74","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jaci.2007.07.023","article-title":"Exposure of infants to budesonide through breast milk of asthmatic mothers","volume":"120","author":"F\u00e4lt","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ekir.2025.04.038_bib75","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/rheumatology\/kex039","article-title":"Low level of rituximab in human breast milk in a patient treated during lactation","volume":"56","author":"Bragnes","year":"2017","journal-title":"Rheumatol (Oxf Engl)"},{"key":"10.1016\/j.ekir.2025.04.038_bib76","article-title":"Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions","volume":"7","author":"Krysko","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.ekir.2025.04.038_bib77","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s40744-021-00313-z","article-title":"Rituximab and canakinumab use during lactation: no detectable serum levels in breastfed infants","volume":"8","author":"Bosshard","year":"2021","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.ekir.2025.04.038_bib78","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/jnnp-2022-329545","article-title":"Safety of breast feeding during rituximab treatment in multiple sclerosis","volume":"94","author":"R\u00f8d","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ekir.2025.04.038_bib79","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/acn3.51893","article-title":"Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditions","volume":"10","author":"Anderson","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.ekir.2025.04.038_bib80","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/AOG.0000000000003654","article-title":"Diffuse large B-cell lymphoma during third-trimester pregnancy and lactation","volume":"135","author":"Hersey","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ekir.2025.04.038_bib81","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000723","article-title":"Monoclonal antibody treatment during pregnancy and\/or lactation in women with MS or neuromyelitis optica spectrum disorder","volume":"7","author":"Ciplea","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.ekir.2025.04.038_bib82","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/bfm.2020.0068","article-title":"Belimumab concentrations in maternal serum and breast milk during breastfeeding and the safety assessment of the infant: a case study","volume":"15","author":"Saito","year":"2020","journal-title":"Breastfeed Med"},{"key":"10.1016\/j.ekir.2025.04.038_bib83","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/bcp.15876","article-title":"Establishment of a measurement system to evaluate breast milk transfer of biological agents using dry filter paper: A multi-institutional study","volume":"90","author":"Saito","year":"2024","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ekir.2025.04.038_bib84","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001167","article-title":"Concentrations of subcutaneously administered Belimumab in human breast milk of a woman with systemic lupus erythematosus: a case report","volume":"11","author":"Blomjous","year":"2024","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.ekir.2025.04.038_bib85","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semarthrit.2014.05.006","article-title":"Use of Belimumab throughout pregnancy to treat active systemic lupus erythematosus: a case report","volume":"44","author":"Danve","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ekir.2025.04.038_bib86","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJMoa1502950","article-title":"Eculizumab in pregnant patients with paroxysmal nocturnal hemoglobinuria","volume":"373","author":"Kelly","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2025.04.038_bib87","first-page":"2288","article-title":"[Pregnancy and delivery in a PNH patient treated with eculizumab]","volume":"55","author":"Ando","year":"2014","journal-title":"Rinsho Ketsueki"},{"issue":"suppl 1","key":"10.1016\/j.ekir.2025.04.038_bib88","doi-asserted-by":"crossref","first-page":"A119.2","DOI":"10.1136\/fetalneonatal-2012-301809.388","article-title":"Pregnancy outcome and safety of breast-feeding in two patients with paroxysmal nocturnal haemoglobinuria (PNH) treated with eculizumab","volume":"97","author":"Sarris","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.ekir.2025.04.038_bib89","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s12185-016-1946-x","article-title":"Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review","volume":"103","author":"Miyasaka","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ekir.2025.04.038_bib90","first-page":"36","article-title":"Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis","volume":"4","author":"Sharma","year":"2015","journal-title":"Leuk Res Rep"},{"key":"10.1016\/j.ekir.2025.04.038_bib91","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1182\/blood.V128.22.2397.2397","article-title":"The pregnancy course and outcomes during targeted therapy of paroxysmal nocturnal hemoglobinuria","volume":"128","author":"Vinogradova","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2025.04.038_bib92","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.15790","article-title":"Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis","volume":"185","author":"Soci\u00e9","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ekir.2025.04.038_bib93","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2025.04.038_bib94","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"The EMPA-KIDNEY Collaborative Group","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2025.04.038_bib98","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ecco-jcc\/jju006","article-title":"The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease","volume":"9","author":"van der Woude","year":"2015","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ekir.2025.04.038_bib99","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.kint.2022.10.029","article-title":"Glomerular diseases in pregnancy: pragmatic recommendations for clinical management","volume":"103","author":"Fakhouri","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2025.04.038_bib100","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.kint.2015.12.050","article-title":"Pregnancy across the spectrum of chronic kidney disease","volume":"89","author":"Hladunewich","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2025.04.038_bib101","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.reprotox.2009.02.007","article-title":"Tetrada of the possible mycophenolate mofetil embryopathy: a review","volume":"28","author":"Merlob","year":"2009","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ekir.2025.04.038_bib102","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/ajmg.a.33934","article-title":"An additional patient with mycophenolate mofetil embryopathy: cardiac and facial analyses","volume":"155","author":"Lin","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ekir.2025.04.038_bib103","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13006-022-00514-4","article-title":"Breastfeeding by a mother taking cyclosporine for nephrotic syndrome","volume":"17","author":"Li","year":"2022","journal-title":"Int Breastfeed J"},{"key":"10.1016\/j.ekir.2025.04.038_bib104","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0022-3476(85)80259-6","article-title":"Prednisolone excretion in human milk","volume":"106","author":"\u00d6st","year":"1985","journal-title":"J Pediatr"},{"key":"10.1016\/j.ekir.2025.04.038_bib105","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/jcph.1122","article-title":"Prednisone pharmacokinetics during pregnancy and lactation","volume":"58","author":"Ryu","year":"2018","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ekir.2025.04.038_bib106","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(23)01554-4","article-title":"Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial","volume":"402","author":"Lafayette","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2025.04.038_bib110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fnut.2020.00130","article-title":"Partial degradation of recombinant antibody functional activity during infant gastrointestinal digestion: implications for oral antibody supplementation","volume":"7","author":"Sah","year":"2020","journal-title":"Front Nutr"},{"key":"10.1016\/j.ekir.2025.04.038_bib113","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2025.04.038_bib118","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s40262-021-01025-x","article-title":"Clinical pharmacokinetics of oral semaglutide: analyses of data from Clinical Pharmacology trials","volume":"60","author":"Overgaard","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ekir.2025.04.038_bib127","doi-asserted-by":"crossref","first-page":"844","DOI":"10.2215\/CJN.07911109","article-title":"Pregnancy and chronic kidney disease: a challenge in all CKD stages","volume":"5","author":"Piccoli","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2025.04.038_bib128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrneph.2017.187","article-title":"Reproductive health and pregnancy in women with chronic kidney disease","volume":"14","author":"Wiles","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2025.04.038_bib129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2125.1994.tb04331.x","article-title":"A novel index for expressing exposure of the infant to drugs in breast milk","volume":"38","author":"Ito","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ekir.2025.04.038_bib130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/17425255.2023.2221847","article-title":"Safety of medicines during breastfeeding - from case report to modeling: a contribution from the ConcePTION project","volume":"19","author":"Cardoso","year":"2023","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.ekir.2025.04.038_bib131","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/psp4.13043","article-title":"Physiologically-based pharmacokinetic model to predict doxorubicin and paclitaxel exposure in infants through breast milk","volume":"12","author":"Damoiseaux","year":"2023","journal-title":"CPT Pharmacometr Syst Pharmacol"},{"key":"10.1016\/j.ekir.2025.04.038_bib132","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/cpt.2912","article-title":"Physiologically based pharmacokinetic modeling to determine the impact of CYP2B6 genotype on efavirenz exposure in children, mothers and breastfeeding infants","volume":"114","author":"Pan","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ekir.2025.04.038_bib133","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/clpt.2011.23","article-title":"Prediction of infant drug exposure through breastfeeding: population PK modeling and simulation of fluoxetine exposure","volume":"89","author":"Panchaud","year":"2011","journal-title":"Clin Pharmacol Ther"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024925002633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024925002633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T19:30:46Z","timestamp":1754508646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024925002633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":113,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2468024925002633"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2025.04.038","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of Drugs in Breastfeeding Women With CKD","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2025.04.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}